Lisata Therapeutics LSTA
NASDAQ LSTA
$1.55 +0.11 (+7.69%)
As of: Oct 1, 2026 · 1:38 PM EDT

Lisata Therapeutics (LSTA) Non Operating Income (2010 - 2026)

Updated

Lisata Therapeutics (LSTA) posted Non Operating Income of $1.06 million for Q2 2026, up 408.6% from $209,000 a year earlier.

Analysis

Lisata Therapeutics (LSTA) Non Operating Income (2010 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Non Operating Income at Lisata Therapeutics was $1.42 million, up 27.3% year-over-year; for FY2025, it was $661,000, down 59.3% from FY2024.

  • Annual Non Operating Income shows a five-year compound annual growth rate of 38.0% (FY2020 to FY2025).
  • In prior years, Lisata Therapeutics' Non Operating Income was $1.63 million in FY2024 (-35.9%), $2.54 million in FY2023 (+182.9%), $897,000 in FY2022 and $76,000 in FY2021 (-42.4%).
  • The Q2 2026 figure stands as the highest quarterly Non Operating Income since Q4 2015.
  • On a year-over-year basis, Non Operating Income increased in 1 of the last eight quarters, with growth averaging 2.5%.
  • The strongest year-over-year quarter for Non Operating Income in the past five years was Q4 2022, with growth of 900.0%; the weakest was Q4 2025, with a decline of 63.1%.
  • According to Business Quant data, Non Operating Income for the three prior quarters was $66,000 (Q1 2026), $125,000 (Q4 2025) and $165,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -73.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 387.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Lisata Therapeutics 13.13 Mn 12.88 Mn - 1.06 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.06 Mn
Mar 31, 2026 66,000.00
Dec 31, 2025 125,000.00
Sep 30, 2025 165,000.00
Jun 30, 2025 209,000.00
Mar 31, 2025 161,000.00
Dec 31, 2024 339,000.00
Sep 30, 2024 406,000.00
Jun 30, 2024 479,000.00
Mar 31, 2024 402,000.00
Dec 31, 2023 660,000.00
Sep 30, 2023 703,000.00
Jun 30, 2023 518,000.00
Mar 31, 2023 657,000.00
Dec 31, 2022 550,000.00
Sep 30, 2022 337,000.00
Jun 30, 2022 94,000.00
Mar 31, 2022 -85,000.00
Dec 31, 2021 55,000.00
Sep 30, 2021 41,000.00
API Access

Lisata Therapeutics Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-income&ticker=LSTA&period=max&api_key=YOUR_API_KEY